Expression and function of fibroblast growth factor-inducible 14 in human corneal myofibroblasts

Experimental Eye Research

Volumn 89, Issue 2, 2009, Pages 256-262

  Ebihara, Nobuyuki ^a   Nakayama, Masafumi ^a   Tokura, Tomoko ^a   Ushio, Hiroko ^a   Murakami, Akira ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

chemokines; corneal myofibroblast; fibroblast growth factor inducible 14 (Fn14); keratocytes; matrix metalloproteinases; TGF 1; tumor necrosis factor like weak inducer of apoptosis (TWEAK); wound healing

Indexed keywords

CHEMOKINE; FIBROBLAST GROWTH FACTOR INDUCIBLE 14; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR LIKE INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CORNEA CELL; CORNEA DISEASE; CYTOKINE PRODUCTION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KERATINOCYTE; MYOFIBROBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; WOUND HEALING;

ACTINS; AGED; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINES; CORNEA; DRUG INTERACTIONS; EYE PROTEINS; FIBROBLAST GROWTH FACTORS; FIBROBLASTS; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHORYLATION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTORS; WOUND HEALING;

EID: 67650417926     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.03.014     Document Type: Article

References (42)

1. Ando T., Ichikawa J., Wako M., Hatsushika K., Watanabe Y., Sakuma M., Tasaka K., Ogawa H., Hamada Y., Yagita H., and Nakao A. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells. Arthritis Res. Ther. 8 (2006) R146
2. Biao Hu., Zhe Wu., and Phan Sem H. Smad3 mediates transforming growth factor-β-Induced α-smooth muscle actin expression. Am. J. Respir. Cell Mol. Biol. 29 (2003) 397-404
3. Campbell S., Michaelson J., Burkly L., and Putterman C. The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity. Front Biosci. 9 (2004) 2273-2284
4. Chicheportiche Y., Bourdon P.R., Xu H., Hsu Y.M., Scott H., Hession C., Garcia I., and Browning J.L. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272 (1997) 32401-32410
5. Chicheportiche Y., Chicheportiche R., Sizing I., Thompson J., Benjamin C.B., Ambrose C., and Dayer J.M. Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies. Arthritis Res. 4 (2002) 126-133
6. Desmoulière A., Geinoz A., Gabbiani F., and Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122 (1993) 103-111
7. Dogra C., Changotra H., Mohan S., and Kumar A. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein. J. Biol. Chem. 281 (2006) 10327-10336
8. Donohue P.J., Richards C.M., Brown S.A., Hanscom H.N., Buschman J., Thangada S., Hla T., Williams M.S., and Winkles J.A. TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 594-600
9. Ebihara N., Yamagami S., Chen L., Tokura T., Iwatsu M., Ushio H., and Murakami A. Expression and function of Toll-like receptor-3 and -9 in human corneal myofibroblasts. Invest. Ophthalmol. Vis. Sci. 48 (2007) 3069-3076
10. Feng S.L.Y., Guo Y., Factor V.M., Thorgeirsson S.S., Bell D.W., Testa J.R., Peifley K.A., and Winkles J.A. The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinoma. Am. J. Pathol. 156 (2000) 1253-1261
11. Fini M.E. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog. Retin. Eye Res. 18 (1999) 529-551
12. Folger P.A., Zekaria D., Grotendorst G., and Masur S.K. Transforming growth factor-beta-stimulated connective tissue growth factor expression during corneal myofibroblast differentiation. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2534-2541
13. Girgenrath M., Weng S., Kostek C.A., Browning B., Wang M., Brown S.A., Winkles J.A., Michaelson J.S., Allaire N., Schneider P., Scott M.L., Hsu Y.M., Yagita H., Flavell R.A., Miller J.B., Burkly L.C., and Zheng T.S. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J. 25 (2006) 5826-5839
14. Harada N., Nakayama M., Nakano H., Fukuchi Y., Yagita H., and Okumura K. Proinflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 299 (2002) 488-493
15. Ho D.H., Vu H., Brown S.A., Donohue P.J., Hanscom H.N., and Winkles J.A. Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice. Cancer Res. 64 (2004) 8968-8972
16. Hosokawa Y., Hosokawa I., Ozaki K., Nakae H., and Matsuo T. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts. Clin. Exp. Immunol. 146 (2006) 540-549
17. Jakubowski A., Browning B., Lukashev M., Sizing I., Thompson J.S., Benjamin C.D., Hsu Y.M., Ambrose C., Zheng T.S., and Burkly L.C. Dual role for TWEAK in angiogenic regulation. J. Cell Sci. 115 (2002) 267-274
18. Jester J.V., Petroll W.M., and Barry P.A. Cavanagh HD. Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest. Ophthalmol. Vis. Sci. 36 (1995) 809-819
19. Jester J.V., Barry-Lane P.A., Cavanagh H.D., and Petroll W.M. Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea 15 (1996) 505-516
20. Jester J.V., Huang J., Barry-Lane P.A., Kao W.W., Petroll W.M., and Cavanagh H.D. Transforming growth factor(beta)-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. Invest. Ophthalmol. Vis. Sci. 40 (1999) 1959-1967
21. Jester J.V., Petroll W.M., and Cavanagh H.D. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Prog. Retin. Eye Res. 18 (1999) 311-356
22. Jin L., Nakao A., Nakayama M., Yamaguchi N., Kojima Y., Nakano N., Tsuboi R., Okumura K., Yagita H., and Ogawa H. Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes. J. Invest. Dermatol. 122 (2004) 1175-1179
23. Joseph A., Hossain P., Jham S., Jones R.E., Tighe P., McIntosh R.S., and Dua H.S. Expression of CD34 and L-selectin on human corneal keratocytes. Invest. Ophthalmol. Vis. Sci. 44 (2003) 4689-4692
24. Kamata K., Kamijo S., Nakajima A., Koyanagi A., Kurosawa H., Yagita H., and Okumura K. Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis. J. Immunol. 177 (2006) 6433-6439
25. Kawakita T., Shiraki K., Yamanaka Y., Yamaguchi Y., Saitou Y., Enokimura N., Yamamoto N., Okano H., Sugimoto K., Murata K., and Nakano T. Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis. Biochem. Biophys. Res. Commun. 318 (2004) 726-733
26. Lynch C.N., Wang Y.C., Lund J.K., Chen Y.W., Leal J.A., and Wiley S.R. TWEAK induces angiogenesis and proliferation of endothelial cells. J. Biol. Chem. 274 (1999) 8455-8459
27. Meighan-Mantha R.L., Hsu D.K., Guo Y., Guo Y., Brown S.A., Feng S.L., Peifley K.A., Alberts G.F., Copeland N.G., Gilbert D.J., Jenkins N.A., Richards C.M., and Winkles J.A. The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J. Biol. Chem. 274 (1999) 33166-33176
28. Nakayama M., Kayagaki N., Yamaguchi N., Okumura K., and Yagita H. Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity. J. Exp. Med. 192 (2000) 1373-1380
29. Nakayama M., Ishidoh K., Kayagaki N., Kojima Y., Yamaguchi N., Nakano H., Kominami E., Okumura K., and Yagita H. Multiple pathways of TWEAK-induced cell death. J. Immunol. 168 (2002) 734-743
30. Nakayama M., Ishidoh K., Kojima Y., Harada N., Kominami E., Okumura K., and Yagita H. Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death. J. Immunol. 170 (2003) 341-348
31. Perper S.J., Browning B., Burkly L.C., Weng S., Gao C., Giza K., Su L., Tarilonte L., Crowell T., Rajman L., Runkel L., Scott M., Atkins G.J., Findlay D.M., Zheng T.S., and Hess H. TWEAK is a novel arthritogenic mediator. J. Immunol. 177 (2006) 2610-2620
32. Potrovita I., Zhang W., Burkly L., Hahm K., Lincecum J., Wang M.Z., Maurer M.H., Rossner M., Schneider A., and Schwaninger M. Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration. J. Neurosci. 24 (2004) 8237-8244
33. Saitoh T., Nakayama M., Nakano H., Yagita H., Yamamoto N., and Yamaoka S. TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. J. Biol. Chem. 278 (2003) 36005-36012
34. Sumiyoshi K., Nakao A., Setoguchi Y., Okumura K., Tsuboi R., and Ogawa H. Smads regulate collagen gel contraction by human dermal fibroblasts. Br. J. Dermatol. 149 (2003) 464-470
35. Toti P., Tosi G.M., Traversi C., Schürfeld K., Cardone C., and Caporossi A. CD-34 stromal expression pattern in normal and altered human corneas. Ophthalmology 109 (2002) 1167-1171
36. Tsuchihashi H., Hasegawa T., Sumiyoshi K., Ogawa H., Ikeda S., Ando T., Nakao A., and Okumura K. TWEAK inhibits TGF-beta-induced contraction of normal and keloid fibroblast-embedded collagen gel. J. Dermatol. Sci. 45 (2007) 216-218
37. Wiley S.R., Cassiano L., Lofton T., Davis-Smith T., Winkles J.A., Lindner V., Liu H., Daniel T.O., Smith C.A., and Fanslow W.C. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15 (2001) 837-846
38. Wiley S.R., and Winkles J.A. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Cytokine Growth Factor Rev. 14 (2003) 241-249
39. Winkles J.A. The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat. Rev. Drug Discov. 7 (2008) 411-425
40. Xu H., Okamoto A., Ichikawa J., Ando T., Tasaka K., Masuyama K., Ogawa H., Yagita H., Okumura K., and Nakao A. TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF. Biochem. Biophys. Res. Commun. 318 (2004) 422-427
41. Yuan W., and Varga J. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J. Biol. Chem. 276 (2001) 38502-38510
42. Zhao Z., Burkly L.C., Campbell S., Schwartz N., Molano A., Choudhury A., Eisenberg R.A., Michaelson J.S., and Putterman C. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. J. Immunol. 179 (2007) 7949-7958